脓毒症早期预警生物标志物的研究进展

doi:10.3969/j.issn.1673-8640.2015.05.029

摘要/Abstract

摘要：

脓毒症是指由感染引起的全身炎症反应综合征(SIRS),临床上证实有细菌存在或有高度可疑感染灶。近期关于脓毒症早期诊断的研究备受关注。文章结合脓毒症的发病机制阐述细胞因子、降钙素原(PCT)、内毒素、高敏C反应蛋白(hs-CRP)、血清淀粉样蛋白A(SAA)、肝素结合蛋白(HBP)、(1,3)β-D葡聚糖(BG)及半乳甘露聚糖(GM)等标志物诊断早期脓毒症、评估疾病严重程度及判断预后的研究进展,为脓毒症早期诊断和治疗提供新的思路。

关键词: 脓毒症, 细胞因子, 降钙素原, 内毒素, 高敏C反应蛋白, 血清淀粉样蛋白A, 肝素结合蛋白, (1,3)β-D葡聚糖, 半乳甘露聚糖

Abstract:

Sepsis is a kind of systemic inflammatory response syndromes(SIRS) induced by infection, which has been clinically confirmed the presence of bacteria or highly suspicious infections. More and more researchers have paid attention to the early diagnosis of sepsis recently. This review has focused on the capabilities of cytokine, procalcitonin(PCT), endotoxin, high-sensitivity C reactive protein(hs-CRP), serum amyloid protein A(SAA), heparin-binding protein(HBP), (1,3)-beta-D-glucan(BG) and galactomannan(GM) to diagnose sepsis early and assess the severity and prognosis, in order to provide new thoughts for the early diagnosis and treatment of sepsis.

Key words: Sepsis, Cytokine, Procalcitonin, Endotoxin, High-sensitivity C reactive protein, Serum amyloid protein A, Heparin-binding protein, (1,3)-beta-D-glucan, Galactomannan

中图分类号:

R446.5

许程, 徐元宏. 脓毒症早期预警生物标志物的研究进展[J]. 检验医学, 2015, 30(5): 533-536.

XU Cheng, XU Yuanhong. The research progress of early warning biomarker for sepsis[J]. Laboratory Medicine, 2015, 30(5): 533-536.

参考文献 28

[1]	GAIESKI DF, EDWARDS JM, KALLAN MJ, et al.Benchmarking the incidence and mortality of severe sepsis in the United States[J]. Crit Care Med, 2013, 41(5):1167-1174.
[2]	GUSTOT T.Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response[J]. Curr Opin Crit Care, 2011, 17(2):153-159.
[3]	LI L, ZHU Z, CHEN J, et al.Diagnostic value of soluble triggering receptor expressed on myeloid cells-1 in critically-ill, postoperative patients with suspected sepsis[J]. Am J Med Sci, 2013, 345(3):178-184.
[4]	ABDOLLAHI A, SHOAR S, NAYYERI F, et al.Diagnostic value of simultaneous measurement of procalcitonin, interleukin-6 and hs-CRP in prediction of early-onset neonatal sepsis[J]. Mediterr J Hematol Infect Dis, 2012, 4(1):e2012028.
[5]	UUSITALO-SEPPÄLÄ R, KOSKINEN P, LEINO A, et al. Early detection of severe sepsis in the emergency room: diagnostic value of plasma C-reactive protein, procalcitonin, and interleukin-6[J]. Scand J Infect Dis, 2011, 43(11-12):883-890.
[6]	SRISANGTHONG P, WONGSA A, KITTIWORAWITKUL P, et al.Early IL-6 response in sepsis is correlated with mortality and severity score[J]. Crit Care, 2013, 17(Suppl 2):334-339.
[7]	SHERWIN C, BROADBENT R, YOUNG S, et al.Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis[J]. Am J Perinatol, 2008, 25(10):629-636.
[8]	SONG R, KIM J, YU D, et al.Kinetics of IL-6 and TNF-α changes in a canine model of sepsis induced by endotoxin[J]. Vet Immunol Immunopathol, 2012, 146(2):143-149.
[9]	PACHOT A, MONNERET G, VOIRIN N, et al.Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock[J]. Clin Immunol, 2005, 114(1):61-99.
[10]	SCICLUNA BP, VAN DER POLL T. Interleukin-27: a potential new sepsis biomarker exposed through genome-wide transcriptional profiling[J]. Crit Care, 2012, 16(6):188.
[11]	WONG HR, CVIJANOVICH NZ, HALL M, et al.Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children[J]. Crit Care, 2012, 16(5):R213.
[12]	LIU HL, LIU GH, MA QB.Value of procalcitonin in the early diagnosis of sepsis in department of emergency[J]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2012, 24(5):298-301.
[13]	赵玉玲. 降钙素原对脓毒症早期诊断的临床意义[J]. 检验医学, 2006,21(4):431.
[14]	RAJKUMARI N, MATHUR P, SHARMA S, et al.Procalcitonin as a predictor of sepsis and outcome in severe trauma patients: a prospective study[J]. J Lab Physicians, 2013, 5(2):100-108.
[15]	TIAN G, PAN SY, MA G, et al.Serum levels of procalcitonin as a biomarker for differentiating between sepsis and systemic inflammatory response syndrome in the neurological intensive care unit[J]. J Clin Neurosci, 2014, 21(7):1153-1158.
[16]	ZAHAR JR, TIMSIT JF, GARROUSTE-ORGEAS M, et al.Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality[J]. Crit Care Med, 2011, 39(8):1886-1895.
[17]	KATAGIRI D, DOI K, MATSUBARA T, et al.New biomarker panel of plasma neutrophil gelatinase-associated lipocalin and endotoxin activity assay for detecting sepsis in acute kidney injury[J]. J Crit Care, 2013, 28(5):564-570.
[18]	SHIMIZU T, OBATA T, SONODA H, et al.Diagnostic potential of endotoxin scattering photometry for sepsis and septic shock[J]. Shock, 2013, 40(6):504-511.
[19]	WANG HE, SHAPIRO NI, GRIFFIN R, et al.Inflammatory and endothelial activation biomarkers and risk of sepsis: a nested case-control study[J]. J Crit Care, 2013, 28(5):549-555.
[20]	刘德贝, 曹艳林, 邹飞扬, 等. 超敏CRP、IL-6及PCT对新生儿脓毒症早期诊断的意义[J]. 国际检验医学杂志, 2010,31(3):212-213.
[21]	ARNON S, LITMANOVITZ I, REGEV R, et al.Serum amyloid A protein is a useful inflammatory marker during late-onset sepsis in preterm infants[J]. Biol Neonate, 2005, 87(2):105-110.
[22]	FENDLER WM, PIOTROWSKI AJ.Procalcitonin in the early diagnosis of nosocomial sepsis in preterm neonates[J]. J Paediatr Child Health, 2008, 44(3):114-118.
[23]	YUAN H, HUANG J, LV B, et al.Diagnosis value of the serum amyloid A test in neonatal sepsis: a meta-analysis[J]. Biomed Res Int, 2013, 2013:520294.
[24]	CHEW MS, LINDER A, SANTEN S, et al.Increased plasma levels of heparin-binding protein in patients with shock: a prospective, cohort study[J]. Inflamm Res, 2012, 61(4):375-379.
[25]	LINDER A, AKESSON P, INGHAMMAR M, et al.Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock[J]. Crit Care, 2012, 16(3):R90.
[26]	LINDER A, CHRISTENSSON B, HERWALD H, et al.Heparin-binding protein: an early marker of circulatory failure in sepsis[J]. Clin Infect Dis, 2009, 49(7):1044-1050.
[27]	SHANE AL, STOLL BJ.Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis[J]. Am J Perinatol, 2013, 30(2):131-141.
[28]	POSTERARO B, DE PASCALE G, TUMBARELLO M, et al.Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of(1→ 3)-β-D-glucan assay, Candida score, and colonization index[J]. Crit Care, 2011, 15(5):R224.